Wednesday, March 17, 2010

Toshiba Highlights Ultrasound Cardiac Capabilities At ACC 2010

ATLANTA, March 16, 2010 – Health care facilities use ultrasound as a first-line diagnostic exam to quickly and efficiently perform a range of patient exams, including cardiac imaging. Developed to meet these demanding clinical needs, Toshiba America Medical Systems, Inc. will showcase the advanced cardiac capabilities of its AplioTM MX and Aplio ArtidaTM ultrasound systems at this year’s American College of Cardiology (ACC) annual meeting in Atlanta, March 14 – 16, 2010 (Booth # 1944). This is the first appearance of the Aplio MX at ACC.

Introduced in November 2009, Toshiba’s new Aplio MX ultrasound system is a mid-sized, cart-based system that improves patient care by offering increased portability and patient access, with the ability to perform premium ultrasound exams using this smaller system. The functional Aplio MX allows physicians to quickly and efficiently perform a range of advanced ultrasound exams, including cardiac, on patients when space is limited, such as in the emergency department, intensive care unit, outside the lab and at the patient’s bedside.

Features of the Aplio MX include:
• Contrast Harmonics to provide the ability to use bubble based contrast agents that help to provide better tissue definition on difficult-to-image patients during echocardiograms.

• Differential Tissue Harmonic Imaging for the better imaging of difficult-to-image patients, like bariatric, without sacrificing resolution to give superior border and tissue definition.

• ApliPure+ to enhance both image clarity and detail definition with real-time compounding technology to simultaneously perform spatial and frequency compounding during transmitting and receiving.

• Advanced Dynamic Flow to provide color Doppler imaging at an unprecedented level and show flow with directional information for even the smallest vessels.

• Tissue Doppler Imaging Quantification (TDIQ) software to perform various analyses by Angle Corrected Displacement and Strain to measure myocardial viability.

source: Toshiba Medical

No comments: